These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15725047)

  • 21. Is the use of benzalkonium chloride as a preservative for nasal formulations a safety concern? A cautionary note based on compromised mucociliary transport.
    Bernstein IL
    J Allergy Clin Immunol; 2000 Jan; 105(1 Pt 1):39-44. PubMed ID: 10629450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Medically-induced rhinitis].
    Nosulya EV
    Vestn Otorinolaringol; 2017; 82(3):84-90. PubMed ID: 28631690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rhinitis medicamentosa: an increasing therapeutical problem].
    Betlejewski S
    Otolaryngol Pol; 1997; 51(1):53-7. PubMed ID: 9518316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of rhinitis medicamentosa with fluticasone propionate--an experimental study.
    Elwany S; Abdel-Salaam S
    Eur Arch Otorhinolaryngol; 2001 Mar; 258(3):116-9. PubMed ID: 11374251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternatives to Benzalkonium Chloride containing nasal preparations.
    Qureshi AA; Nilssen E
    Clin Otolaryngol; 2015 Aug; 40(4):400-1. PubMed ID: 26179693
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
    Dorn M; Hofmann W; Knick E
    HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study.
    Cam B; Sari M; Midi A; Gergin O
    Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3123-3130. PubMed ID: 31468129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis.
    Graf P; Enerdal J; Hallén H
    Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1128-32. PubMed ID: 10522506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of benzalkonium chloride on histamine H1 receptor mRNA expression in nasal epithelial cells.
    Kawabata M; Ohori J; Kurono Y
    Auris Nasus Larynx; 2016 Dec; 43(6):685-8. PubMed ID: 26946996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhinitis medicamentosa: electron microscopic changes of human nasal mucosa.
    Knipping S; Holzhausen HJ; Goetze G; Riederer A; Bloching MB
    Otolaryngol Head Neck Surg; 2007 Jan; 136(1):57-61. PubMed ID: 17210334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers.
    Hallén H; Graf P
    Clin Exp Allergy; 1995 May; 25(5):401-5. PubMed ID: 7553242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between objective nasal mucosal swelling and estimated stuffiness during long-term use of vasoconstrictors.
    Graf P; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):334-9. PubMed ID: 7530821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The rebound of nasal resistance after decongestant used in nose].
    Shen J; Huang X; Xiang J; Shu H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 13(12):560-1. PubMed ID: 12541428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical hyaluronic acid in rhinitis medicamentosa: could our perspective be changed?
    Casale M; Vella P; Moffa A; Sabatino L; Rinaldi V; Grimaldi V; Salvinelli F
    J Biol Regul Homeost Agents; 2017 Dec; 31(4 Suppl 2):55-62. PubMed ID: 29202563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline.
    Graf P; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(3):157-60. PubMed ID: 7515487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhinitis medicamentosa as a cause of increased intraoperative bleeding.
    Robison JG; Pant H; Ferguson BJ
    Laryngoscope; 2010 Oct; 120(10):2106-7. PubMed ID: 20824778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal changes in rhinitis medicamentosa.
    Lin CY; Cheng PH; Fang SY
    Ann Otol Rhinol Laryngol; 2004 Feb; 113(2):147-51. PubMed ID: 14994772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzalkonium chloride as a preservative in nasal solutions: re-examining the data.
    Graf P
    Respir Med; 2001 Sep; 95(9):728-33. PubMed ID: 11575893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists.
    Fowler J; Chin CJ; Massoud E
    J Otolaryngol Head Neck Surg; 2019 Dec; 48(1):70. PubMed ID: 31818321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhinitis medicamentosa.
    Toohill RJ; Lehman RH; Grossman TW; Belson TP
    Laryngoscope; 1981 Oct; 91(10):1614-21. PubMed ID: 6169966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.